CGON vs INTC · $4.74B cap vs rev $29.70B
CG Oncology, Inc. Common stock (CGON) versus Intel Corporation (INTC) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Intel Corporation (INTC) is a semiconductors company listed on US. It is led by Pat Gelsinger.
CGON does not have a complete income-statement cache yet.
Latest reported INTC revenue for 2026-06-27 was $29.70B. Net income was -$14.76B. INTC currently screens at market cap $498.43B.
CGON currently screens at market cap $4.74B. INTC currently screens at market cap $498.43B.
Not investment advice. Open the CGON and INTC stock pages for the full models.
Not investment advice.